This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Gardea-Resendez M, Coombes BJ, Veldic M, Tye SJ, Romo-Nava F, Ozerdem A, et al. Gardea-Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01888-x
Bessonova L, Ogden K, Doane MJ, O’Sullivan AK, Tohen M. The economic burden of bipolar disorder in the United States: a systematic literature review. Clinicoecon Outcomes Res. 2020;12:481–97.
Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387:1561–72.
Melhuish Beaupre LM, Tiwari AK, Goncalves VF, Lisoway AJ, Harripaul RS, Muller DJ, et al. Antidepressant-associated mania in bipolar disorder: a review and meta-analysis ofpotential clinical and genetic risk factors. J Clin Psychopharmacol. 2020;40:180–5.
Viktorin A, Lichtenstein P, Thase ME, Larsson H, Lundholm C, Magnusson PK, et al. The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer. Am J Psychiatry. 2014;171:1067–73.
Chen CK, Wu LS, Huang MC, Kuo CJ, Cheng AT. Antidepressant treatment and manic switch in bipolar i disorder: a clinical and molecular genetic study. J Pers Med. 2022;12:615.
Gimenez-Palomo A, Dodd S, Anmella G, Carvalho AF, Scaini G, Quevedo J, et al. The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment. Front Psychiatry. 2021;12:546801.
Kornhuber J, Gulbins E New molecular targets for antidepressant drugs. Pharmaceuticals (Basel). 2021;14:894.
Emmerzaal TL, Nijkamp G, Veldic M, Rahman S, Andreazza AC, Morava E, et al. Effect of neuropsychiatric medications on mitochondrial function: For better or for worse. Neurosci Biobehav Rev. 2021;127:555–71.
Scaini G, Andrews T, Lima CNC, Benevenuto D, Streck EL, Quevedo J. Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder. Mitochondrion. 2021;57:23–36.
Scaini G, Barichello T, Fries GR, Kennon EA, Andrews T, Nix BR, et al. TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation. Neuropsychopharmacol. 2019;44:1291–9.
Scaini G, Fries GR, Valvassori SS, Zeni CP, Zunta-Soares G, Berk M, et al. Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients. Transl Psychiatry. 2017;7:e1111.
Mertens J, Wang QW, Kim Y, Yu DX, Pham S, Yang B, et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature. 2015;527:95–9.
Morris G, Walder K, McGee SL, Dean OM, Tye SJ, Maes M, et al. A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev. 2017;74:1–20.
Son JM, Lee C. Aging: all roads lead to mitochondria. Semin Cell Dev Biol. 2021;116:160–8.
Schaffer A, Mamdani M, Levitt A, Herrmann N. Effect of antidepressant use on admissions to hospital among elderly bipolar patients. Int J Geriatr Psychiatry. 2006;21:275–80.
Liang L, Chen J, Xiao L, Wang Q, Wang G. Mitochondrial modulators in the treatment of bipolar depression: a systematic review and meta-analysis. Transl Psychiatry. 2022;12:4.
Funding
The research funding support from University of Texas Health Science Center at Houston, the Louis A. Faillace, MD Endowment Funds and Translational Psychiatry Program to GS and JQ are acknowledged. Translational Psychiatry Program (USA) is funded by the Department of Psychiatry and Behavioral Sciences, McGovern Medical School at UTHealth and Linda Gail Behavioral Health Research Fund. Center of Excellence on Mood Disorders (USA) is funded by the Pat Rutherford Jr Chair in Psychiatry, John S. Dunn Foundation and Anne and Don Fizer Foundation Endowment for Depression Research. Translational Psychiatry Laboratory (Brazil) is funded by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC), Instituto Cérebro e Mente and University of Southern Santa Catarina (UNESC).
Author information
Authors and Affiliations
Contributions
GS drafted the first version of this article, which was critically revised by JQ. In total, both authors contributed equally to this work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests, and funding body had no role in the design of the study, collection and analysis of data, or decision to publish.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Scaini, G., Quevedo, J. The conundrum of antidepressant use in bipolar disorder. Mol Psychiatry 28, 972–973 (2023). https://doi.org/10.1038/s41380-022-01930-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-022-01930-y